The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism. En savoir plus sur The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.
Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer. En savoir plus sur Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors. En savoir plus sur An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.
[Sarcoid-like granulomatosis in cancer patients treated with immune checkpoints inhibitors]. En savoir plus sur [Sarcoid-like granulomatosis in cancer patients treated with immune checkpoints inhibitors].